✦ LIBER ✦

43 Cis platinum diammine dichloride (cis PDD) in advanced ovarian cancer

✍ Scribed by Wiltshaw, E.

Book ID: 122781710
Publisher: Elsevier Science
Year: 1978
Tongue: English
Weight: 212 KB
Volume: 60
Category: Article
ISSN: 0300-9084
DOI: 10.1016/S0300-9084(78)80633-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adriamycin and cis-platinum in advanced

Adriamycin and cis-platinum in advanced ovarian cancer

✍ de Gramont, Aimery; Drolet, Yvan; Lavoie, Andre; Painchaud, Marc; Blouin, Rene; 📂 Article 📅 1985 🏛 Elsevier Science ⚖ 480 KB

cis-Platinum-hexamethylmelamine therapy

cis-Platinum-hexamethylmelamine therapy of advanced ovarian cancer

✍ JoséA. Lopez; John G. Krikorian; Sylvia F. Dias; Alexander S.D. Spiers; Harvey E 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Combined cyclophosphamide, adriamycin an

Combined cyclophosphamide, adriamycin and cis-platinum in advanced ovarian cancer resistant to chlorambucil and cis-platinum

✍ G.J. Mann; L.T. Malden; H.J. Solomon; M.H.N. Tattersall 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Study of Cis-diammine-dichloro-platinum

Study of Cis-diammine-dichloro-platinum in advanced soft tissue sarcoma: Protocol 62781, March 1978

✍ H.M. Pinedo; C.P.J. Vendrik; M. Staquet; R. Sylvester 📂 Article 📅 1978 🏛 Elsevier Science ⚖ 298 KB

COMBINATION CHEMOTHERAPY WITH CIS-DIAMMI

COMBINATION CHEMOTHERAPY WITH CIS-DIAMMINE-DICHLORO-PLATINUM, VINBLASTINE, AND BLEOMYCIN IN ADVANCED TESTICULAR NON-SEMINOMA

✍ Stoter, G; Sleijfer, D.Th; Vendrik, C.P.J; Koops, H.Schraffordt; Struyvenberg, A 📂 Article 📅 1979 🏛 The Lancet 🌐 English ⚖ 662 KB

cis-platinum, adriamycin, and hexamethyl

cis-platinum, adriamycin, and hexamethylmelamine versus cyclophosphamide in advanced ovarian carcinoma

✍ J. Carmo-Pereira; F. Oliveira Costa; Elvira Henriques 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 411 KB

Fifty-three evaluable patients with disseminated ovarian carcinoma (FIGO Ill or IV) not treated with prior chemotherapy were randomized to receive either combination chemotherapy consisting of cis-platinum 40 mg/m e IV on day 1, adriamycin 40 mg/m 2 IV on day 1, and hexamethylmelamine 150 mg/m 2 PO